 | Up a level |
Journal Article
Adler, C., Halbach, M., Adler, J., Michels, G. and Reuter, H. (2018). Differential Diagnostic Importance of the PR Segment in the Interpretation of the ECG. Med. Klin.-Intensivmed Notfallmed., 113 (1). S. 50 - 53. NEW YORK: SPRINGER. ISSN 2193-6218
Halbach, M., Abraham, W. T., Butter, C., Ducharme, A., Klug, D., Little, W. C., Lovett, E., Schafer, J. E., Senni, E., Swarup, V., Wachter, R., Weaver, F. A., Zile, M. R. and Muller-Ehmsen, J. (2016). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. Eur. Heart J., 37. S. 724 - 726. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Halbach, M. and Baldus, S. (2018). Certification. Pro: indispensable component of quality. Herz, 43 (6). S. 484 - 490. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Halbach, M. and Baldus, S. (2018). Platelet Aggregation Inhibitors in Patients with coronary, cerebral and peripheral Macroangiopathy. What, when and how long? (vol 59, pg 288, 2018). Internist, 59 (8). S. 867 - 868. NEW YORK: SPRINGER. ISSN 1432-1289
Halbach, M. and Baldus, S. (2018). Platelet inhibition in patients with coronary, cerebral and peripheral macroangiopathy. What, when and how long? Internist, 59 (3). S. 288 - 304. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Halbach, M., Baldus, S. and Nitschmann, S. (2022). Shortening and De-escalation of dual Antiplatelet Therapy (2022). Internist, 63 (3). S. 346 - 347. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Halbach, M., Fritz, T., Madershahia, N., Pfister, R. and Reuter, H. (2015). Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction. Herz, 40 (7). S. 959 - 966. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Halbach, M., Grothaus, D., Hoffmann, F., Madershahian, N., Kuhr, K., Baldus, S. and Reuter, H. (2017). REDUCED RATE AND DURATION OF HYPERTENSION-RELATED HOSPITALIZATION AFTER TREATMENT WITH BAROREFLEX ACTIVATION THERAPY. J. Hypertens., 35. S. E215 - 2. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5598
Halbach, M., Hickethier, T., Madershahian, N., Brandt, M. C., Hoppe, U. C., Velden, R., Lovett, E. and Muller-Ehmsen, J. (2014). Baroreflex activation therapy in resistant hypertension - acute on/off effects and chronic blood pressure reduction. Eur. Heart J., 35. S. 744 - 746. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Nottebohm, P., Dumitrescu, D., Madershahian, N., Baldus, S., Reuter, H. and Halbach, M. (2018). Baroreflex activation therapy in heart failure with reduced ejection fraction improves cardiopulmonary function during exercise. Eur. Heart J., 39. S. 482 - 483. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Peinkofer, G., Halbach, M., Baumgartner, S., Pfannkuche, K., Krausgrill, B., Ladage, D., Hescheler, J. and Mueller-Ehmsen, J. (2014). Investigation of action potential properties of native atrial and ventricular cardiomyocytes from the early embryonic to the adult stage allows the determination of the developmental stage of iPSCM. Eur. Heart J., 35. S. 448 - 449. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Peinkofer, G., Klinke, A., Maass, M., Urban, K., Lange, M., Saric, T., Mueller-Ehmsen, J., Baldus, S., Hescheler, J. and Halbach, M. (2015). Arrhythmic risk after transplantation of induced pluripotent stem cell derived cardiomyocytes into infarcted mouse hearts. Eur. Heart J., 36. S. 709 - 710. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Peinkofer, G., Klinke, A., Maass, M., Urban, K., Lange, M., Saric, T., Mueller-Ehmsen, J., Baldus, S., Hescheler, J. and Halbach, M. (2016). Susceptibility to induced ventricular tachycardias increases with time after transplantation of induced pluripotent stem cell-derived cardiomyocytes into infarcted mouse hearts. Eur. Heart J., 37. S. 834 - 835. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Peinkofer, G., Maass, M., Burkert, K., Saric, T., Baldus, S., Hescheler, J. and Halbach, M. (2017). Electrical integration and persistence of transplanted induced pluripotent stem cell-derived cardiomyocytes from different developmental stages. Eur. Heart J., 38. S. 532 - 534. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Reuter, H., Hoffmann, F., Zander, W. O., Ulbrich, L., Baldus, S. and Halbach, M. (2017). ARTERIAL HYPERTENSION AS PROGNOSTIC MARKER IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION AND EARLY PERCUTANEOUS CORONARY INTERVENTION. J. Hypertens., 35. S. E29 - 1. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5598
Tichelbaecker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wissmueller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., Baldus, S. and Rosenkranz, S. (2019). Pulmonary hypertension and valvular heart disease. Herz, 44 (6). S. 491 - 502. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Wachter, R., Halbach, M., Bakris, G., Bisognano, J., Haller, H., Beige, J., Kroon, A. A., Nadim, M., Lovett, E., Schafer, J. and de Leeuw, P. W. (2016). SAFETY AND BLOOD PRESSURE EFFECTS OF SECOND-VERSUS FIRST-GENERATION SYSTEM FOR ADMINISTERING BAROREFLEX ACTIVATION THERAPY. J. Hypertens., 34. S. E94 - 1. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5598
Wallbach, M., Halbach, M., Reuter, H., Passauer, J., Lueders, S., Boehning, E., Zenker, D., Mueller, G., Wachter, R. and Koziolek, M. (2016). Baro Receptio Activation Therapy in Patients with previous renal Denervation. Internist, 57. S. S16 - 1. NEW YORK: SPRINGER. ISSN 1432-1289